[慢性心力衰竭的细胞治疗：现状]
[Cell therapy of chronic heart failure: State of the art].
作者信息
Beliy S A, Komok V V
机构信息
State Budgetary Educational Institution of Higher Professional Education, "I. P. Pavlov First St.-Petersburg State Medical University " of the RF Ministry of Health Care.
出版信息
Kardiologiia. 2018(S4):46-54.
The treatment of patients with CHF using autologous bone marrow-derived mononuclear cell fraction (or its derivatives) is a promising therapy for this serious and numerous group of patients. The article analyzed international and Russian experience of using the cell therapy in patients with CHF and possibilities for extensive use of the autologous bone marrow-derived mononuclear cell fraction in clinical practice.
使用自体骨髓来源的单个核细胞组分（或其衍生物）治疗慢性心力衰竭患者，对于这一庞大的重症患者群体而言是一种很有前景的疗法。本文分析了国际上以及俄罗斯在慢性心力衰竭患者中使用细胞疗法的经验，以及在临床实践中广泛应用自体骨髓来源的单个核细胞组分的可能性。
Zotero 插件